glp-1 and liver disease Why are agonists being used to treat patients with nonalcoholic fatty disease? glp 1 cholesterol effect on

IGF-1 is a growth factor, and chronically elevated levels carry theoretical concerns about promoting the growth of pre-existing neoplasms

Mild GI symptoms, such as nausea or bloating, may still arise during the adjustment period and often ease over time

There is no official contraindication to using GLP-1 receptor agonists in patients with hypothyroidism, and these medications do not directly interfere with thyroid hormone production or replacement therapy

By healing one area of your body or life, you can heal so much more

Derivatives or degradation products thereof AHUMAN NECESSITIES A61MEDICAL OR VETERINARY SCIENCE

Subsequent GLP1RA trials including LEADER and SUSTAIN-6 had small populations of patients with established HF, therefore limiting any potential generalizations about HF risk with GLP1RA (54,55)